Flamel Technologies Announces Receipt of Milestone from GlaxoSmithKline
Flamel Technologies announced that it has received a $1 million milestone from its collaborator, GlaxoSmithKline. The milestone payment was triggered by successful completion of activities relating to the manufacturing process for Coreg CR(TM) microparticles. Flamel and GSK completed a supply agreement in December, 2004 under which Flamel is responsible for manufacturing Coreg CR(TM) microparticles.
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Röhm and OQ Chemicals Break Ground on new World-scale Methyl Methacrylate Production Plant at Bay City, Texas

Chemicals in plastic may contribute to weight gain - Plastic consumer products contain chemicals that may promote the development of overweight and obesity

Start-up aims to optimise chemical transports and save millions - Loady closes financing round of 3.2 million euros after spin-off from BASF's business incubator

VSEPR & Shapes of Molecules
The odor of stones

Spectral Evolution - Haverhill, USA
